2JYQ | pdb_00002jyq

NMR structure of the apo v-Src SH2 domain


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 120 
  • Conformers Submitted: 20 
  • Selection Criteria: back calculated data agree with experimental NOESY spectrum 

wwPDB Validation 3D Report Full Report

Validation slider image for 2JYQ

This is version 1.3 of the entry. See complete history

Literature

Structure, dynamics, and binding thermodynamics of the v-Src SH2 domain: Implications for drug design

Taylor, J.D.Ababou, A.Fawaz, R.R.Hobbs, C.J.Williams, M.A.Ladbury, J.E.

(2008) Proteins 73: 929-940

  • DOI: https://doi.org/10.1002/prot.22119
  • Primary Citation Related Structures: 
    2JYQ

  • PubMed Abstract: 

    SH2 domains provide fundamental recognition sites in tyrosine kinase-mediated signaling pathways which, when aberrant, give rise to disease states such as cancer, diabetes, and immune deficiency. Designing specific inhibitors that target the SH2 domain-binding site, however, have presented a major challenge. Despite well over a decade of intensive research, clinically useful SH2 domain inhibitors have yet to become available. A better understanding of the structural, dynamic, and thermodynamic contributions to ligand binding of individual SH2 domains will provide some insight as to whether inhibitor development is possible. We report the first high resolution solution structure of the apo-v-Src SH2 domain. This is accompanied by the analysis of backbone dynamics and pK(a) values within the apo- and peptide-bound states. Our results indicate that the phosphotyrosine (pY) pocket is tightly structured and hence not adaptable to exogenous ligands. On the other hand, the pocket which accommodates residues proximal and C-terminal of the pY (pY + 3) or so-called specificity determining region, is a large dynamic-binding surface. This appears to allow a high level of promiscuity in binding. Binding of a series of synthetic, phosphotyrosyl, peptidomimetic compounds designed to explore interactions in the pY + 3 pocket further demonstrates the ability of the SH2 domain to accommodate diverse ligands. The thermodynamic parameters of these interactions show dramatic enthalpy/entropy compensation. These data suggest that the v-Src SH2 domain does not have a highly specific secondary-binding site, which clearly presents a major hurdle to design selective inhibitors.


  • Organizational Affiliation
    • Department of Biochemistry and Molecular Biology, University College London, Gower Street, London, WC1E 6BT, UK.

Macromolecule Content 

  • Total Structure Weight: 12.19 kDa 
  • Atom Count: 858 
  • Modeled Residue Count: 106 
  • Deposited Residue Count: 106 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Tyrosine-protein kinase transforming protein Src106Rous sarcoma virusMutation(s): 0 
Gene Names: V-SRC
EC: 2.7.10.2
UniProt
Find proteins for P63185 (Rous sarcoma virus subgroup E (strain Schmidt-Ruppin))
Explore P63185 
Go to UniProtKB:  P63185
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP63185
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 120 
  • Conformers Submitted: 20 
  • Selection Criteria: back calculated data agree with experimental NOESY spectrum 

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2008-06-24
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2022-03-16
    Changes: Database references, Derived calculations
  • Version 1.3: 2024-05-29
    Changes: Data collection